Clinical Trial Results TV
Trial / Study: 1191 submissions (showing 46 to 60)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68 | Page 69 | Page 70 | Page 71 | Page 72 | Page 73 | Page 74 | Page 75 | Page 76 | Page 77 | Page 78 | Page 79 | Page 80 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Steven Steinhubl and Dr. C. Michael Gibson Discuss: 3-year Clinical Outcomes In A Nationwide, Randomized, Pragmatic
Dr. Steven R. Steinhubl

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. A. Michael Lincoff and Dr. C. Michael Gibson Discuss: STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxyli
Dr. A. Michael Lincoff, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Prem Pais and Dr. Serge Korjian Discuss: A Polypill For Primary Prevention Of Cardiovascular Disease In Intermediate
Dr. Prem Pais

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Salim Yusuf and Dr. C. Michael Gibson Discuss: Aspirin Alone And In Combination With A Polypill In Cardiovascular Di
Dr. Salim Yusuf

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Va
Dr. Renato Lopes

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitra
Dr. Otavio Berwanger

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Co
Dr. Robert Byrne

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Dean Kereiakes and Dr. C. MIchael Gibson Discuss: OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-W
Dr. Dean Kereiakes

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Andrew Holden and Dr. C. Michel Gibson: ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon
Dr. Andrew Holden

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Ehrin Armstrong and Dr. C. Michael Gibson Discuss: TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventi
Dr. Ehrin Armstrong

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Catalin Toma and Dr. C. Michael Gibson Discuss: FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mech
, Dr. Catalin Toma

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Ajay Kirtane, Dr. Roxana Mehran, Dr. Mamas Mamas and Dr. C. Michael Gibson Discuss: TCT 2020 Daily Wrap-Up - October
Dr. Ajay Kirtane, Dr. Roxana Mehran, Dr. Mamas Mamas

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Philipp Lurz and Dr. C. Michael Gibson Discuss: MITHRAS: A Randomized Trial of ASD Closure After TMVr
Dr. Philipp Lurz

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Disrupt CAD III: Safety and Effectiveness of Intravascular Lithotr
Dr. Dean Kereiakes

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Corrado Tamburino and Dr. C. Michael Gibson Discuss: SCOPE II: A Randomized Trial of Two Self-expanding TAVR Biopros
Dr. Corrado Tamburino